AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 734-740 , November 2009

Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: A clinico-epidemiologic analysis

References 

  1. Hayden MK. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis. 2000;31:1058–1065
  2. Murray BE. Vancomycin-resistant enterococci. Am J Med. 1997;102:284–293
  3. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control. 2006;34:534–536
  4. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis. 2003;37:326–332
  5. McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis. 2006;42:195–203
  6. van den Braak N, Ott A, van Belkum A, van Belkum A, Kluytmans JA, Koeleman JG, et al. Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands. Infect Control Hosp Epidemiol. 2000;21:520–524
  7. Cheong HJ, Song JY, Eom JS, Kim WJ, Choi SJ, Choi JH, et al. Colonization rate, risk factor for acquisition, and genetic diversity of vancomycin-resistant enterococci (VRE) isolated from rectal culture of patients in intensvie care units from ten large hospitals in Korea. Korean J Infect Dis. 2002;34:276–284
  8. Song JY, Hwang IS, Eom JS, Cheong HJ, Bae WK, Park YH, et al. Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean J Intern Med. 2005;20:55–62
  9. Wikler MA. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2006;
  10. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239
  11. Ostrowsky BE, Venkataraman L, D'Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med. 1999;159:1467–1472
  12. Bonten MJ, Slaughter S, Hayden MK, Nathan C, van Voorhis J, Weinstein RA. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med. 1998;26:2001–2004
  13. Jung YH, Lee YS, Ahn JO, Lee HR, Lee JK, Yoo JI, et al. Prevalence and genetic relatedness of vancomycin-resistant enterococci isolated from livestock and humans after ban of avoparcin in Korea. Infect Chemother. 2006;38:17–23
  14. Tacconelli E, Cataldo MA. Vancomycin-resistant enterococci (VRE): transmission and control. Int J Antimicrob Agents. 2008;31:99–106
  15. Byers KE, Anglim AM, Anneski CJ, Farr BM. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 2002;23:207–211
  16. Sakka V, Tsiodras S, Galani L, Antoniadou A, Souli M, Galani I, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect. 2008;14:14–21
  17. Seo YB. The effect of 3rd-generation cephalosporin use restriction on antimicrobial-resistance and clinical outcomes among intensive care unit patients. [dissertation] Seoul: Korea University; 2007;

 Conflict of interest: All authors report no conflicts of interest.

PII: S0196-6553(08)00867-5

doi: 10.1016/j.ajic.2008.09.025

AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 734-740 , November 2009

Article Tools

* Image Usage & Resolution